2020
DOI: 10.1016/j.jaip.2020.07.042
|View full text |Cite
|
Sign up to set email alerts
|

The Role of Immunotherapy and Biologic Treatments in Occupational Allergic Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 58 publications
0
3
0
Order By: Relevance
“…Pharmacologic treatment of OA is similar to that of nonoccupational asthma. Cases of OA caused by latex, flour, or laboratory animals have been successfully treated with immunotherapy [40]. Omalizumab, a monoclonal antibody targeting IgE, has been shown to be effective in reducing asthma exacerbations and improving asthma control in patients with persistent exposure to their offending agent.…”
Section: Managementmentioning
confidence: 99%
See 1 more Smart Citation
“…Pharmacologic treatment of OA is similar to that of nonoccupational asthma. Cases of OA caused by latex, flour, or laboratory animals have been successfully treated with immunotherapy [40]. Omalizumab, a monoclonal antibody targeting IgE, has been shown to be effective in reducing asthma exacerbations and improving asthma control in patients with persistent exposure to their offending agent.…”
Section: Managementmentioning
confidence: 99%
“…Omalizumab, a monoclonal antibody targeting IgE, has been shown to be effective in reducing asthma exacerbations and improving asthma control in patients with persistent exposure to their offending agent. Since a significant proportion of patient with OA have a severe disease, some of them may also be candidates to receive other biologic treatments such as interleukin (IL)-5/IL-5R antagonists, anti-IL-4R or anti-TLSP [40]. However, the effectiveness of biologic therapies in OA needs to be confirmed by studies designed to answer this question.…”
Section: Managementmentioning
confidence: 99%
“…In certain settings, workers with OA may choose to continue working in jobs with reduced allergen exposures where it cannot be totally eliminated. A review that included three studies involving foods (all used wheat flour) concluded that there was increasing but modest evidence of beneficial short- and long-term effects of immunotherapy and safety in worker populations [58]. Dubini et al also reported on the success of sublingual specific immunotherapy (SLIT) for baker's asthma and rhinitis [59].…”
Section: Preventionmentioning
confidence: 99%